Connection

LI-YUAN YU-LEE to Antineoplastic Agents

This is a "connection" page, showing publications LI-YUAN YU-LEE has written about Antineoplastic Agents.
Connection Strength

0.054
  1. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. Oncotarget. 2017 Feb 07; 8(6):10145-10160.
    View in: PubMed
    Score: 0.016
  2. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget. 2016 Sep 20; 7(38):61544-61561.
    View in: PubMed
    Score: 0.015
  3. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res. 2015 Nov 15; 75(22):4949-59.
    View in: PubMed
    Score: 0.014
  4. Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res. 2008 Jun 15; 14(12):3729-36.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.